News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
445,618 Results
Type
Article (22361)
Company Profile (74)
Press Release (423180)
Multimedia
Podcasts (88)
Webinars (13)
Section
Business (158017)
Career Advice (840)
Deals (25018)
Drug Delivery (94)
Drug Development (49691)
Employer Resources (70)
FDA (9111)
Job Trends (8967)
News (225462)
Policy (19116)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Digital (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (797)
Accelerated approval (38)
ADA (32)
Adcomms (12)
Allergies (123)
Alliances (32115)
ALS (109)
Alzheimer's disease (997)
Antibody-drug conjugate (ADC) (277)
Approvals (9614)
Artificial intelligence (452)
ASCO (178)
Autoimmune disease (171)
Automation (33)
Bankruptcy (215)
Belgium (1)
Best Places to Work (6459)
BIO (37)
Biologics (5)
BIOSECURE Act (11)
Biosimilars (189)
BioSpace Insights (76)
Biotechnology (38)
Bladder cancer (108)
Brain cancer (49)
Breast cancer (365)
Cancer (3201)
Cardiovascular disease (309)
Career advice (740)
Career pathing (18)
CAR-T (148)
CDC (11)
CDMO (65)
Celiac Disease (2)
Cell therapy (429)
Cervical cancer (28)
Clinical research (44456)
Collaboration (1397)
Commercialization (7)
Company closure (3)
Compensation (871)
Complete response letters (59)
COVID-19 (1044)
CRISPR (80)
C-suite (1050)
Cystic fibrosis (87)
Data (4719)
Decentralized trials (1)
Denatured (20)
Depression (82)
Dermatology (55)
Diabetes (313)
Diagnostics (3676)
Digital health (30)
Diversity (4)
Diversity, equity & inclusion (20)
Drug discovery (227)
Drug pricing (134)
Drug shortages (16)
Duchenne muscular dystrophy (166)
Earnings (63680)
Editorial (28)
Employer branding (11)
Employer resources (68)
Events (71061)
Executive appointments (923)
FDA (11424)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (11)
Frontotemporal dementia (19)
Funding (964)
Gene editing (129)
Generative AI (37)
Gene therapy (356)
GLP-1 (641)
Government (1827)
Grass and pollen (4)
Guidances (291)
Healthcare (8102)
Hematology (106)
HIV (35)
Huntington's disease (23)
IgA nephropathy (87)
Immunology and inflammation (135)
Immuno-oncology (59)
Indications (142)
Infectious disease (1184)
Inflammatory bowel disease (122)
Inflation Reduction Act (7)
Influenza (41)
Intellectual property (184)
Interviews (101)
IPO (11284)
IRA (33)
Job creations (2727)
Job search strategy (657)
JPM (32)
Kidney cancer (20)
Labor market (49)
Layoffs (304)
Leadership (18)
Legal (5077)
Licensing (20)
Liver cancer (56)
Longevity (18)
Lung cancer (452)
Lymphoma (272)
Machine learning (28)
Management (24)
Manufacturing (795)
Marketing (9)
MASH (137)
Medical affairs (3)
Medical device (5276)
Medtech (5355)
Mergers & acquisitions (14646)
Metabolic disorders (891)
mRNA (93)
Multiple sclerosis (85)
NASH (18)
Netherlands (1)
Neurodegenerative disease (222)
Neuropsychiatric disorders (62)
Neuroscience (1843)
Neurotech (1)
NextGen: Class of 2026 (2905)
Non-profit (1304)
Now hiring (27)
Obesity (414)
Opinion (177)
Ovarian cancer (102)
Pain (172)
Pancreatic cancer (160)
Parkinson's disease (187)
Partnered (17)
Patents (363)
Patient recruitment (364)
Patient selection (1)
Peanut (21)
People (43224)
Peptides (3)
Pharmaceutical (37)
Pharmacy benefit managers (19)
Phase 1 (12510)
Phase 2 (19195)
Phase 3 (16012)
Pipeline (7104)
Policy (175)
Postmarket research (1737)
Preclinical (4969)
Press Release (72)
Prostate cancer (169)
Psychedelics (30)
Radiopharmaceuticals (265)
Rare diseases (724)
Real estate (3878)
Recruiting (27)
Regulatory (15519)
Reports (34)
Research institute (864)
Resumes & cover letters (118)
Rett syndrome (42)
RNA editing (12)
RSV (29)
Schizophrenia (123)
Series A (177)
Series B (122)
Service/supplier (1)
Sickle cell disease (76)
Special edition (13)
Spinal muscular atrophy (98)
Sponsored (17)
Startups (2221)
State (2)
Stomach cancer (8)
Supply chain (83)
Tariffs (71)
The Weekly (66)
Vaccines (398)
Venture capital (65)
Weight loss (233)
Women's health (75)
Worklife (5)
Date
Today (46)
Last 7 days (331)
Last 30 days (1287)
Last 365 days (17207)
2026 (12213)
2025 (17323)
2024 (20335)
2023 (23807)
2022 (32154)
2021 (33665)
2020 (31563)
2019 (24526)
2018 (18857)
2017 (20139)
2016 (19028)
2015 (23047)
2014 (21534)
2013 (17136)
2012 (17003)
2011 (17757)
2010 (16747)
Location
Africa (460)
Alabama (40)
Alaska (3)
Arizona (153)
Arkansas (7)
Asia (28963)
Australia (3949)
California (8010)
Canada (2693)
China (1046)
Colorado (356)
Connecticut (399)
Delaware (251)
Europe (59588)
Florida (1376)
Georgia (175)
Hawaii (3)
Idaho (31)
Illinois (685)
India (107)
Indiana (408)
Iowa (13)
Japan (505)
Kansas (104)
Kentucky (35)
Louisiana (36)
Maine (63)
Maryland (837)
Massachusetts (6408)
Michigan (158)
Minnesota (402)
Mississippi (2)
Missouri (78)
Montana (19)
Nebraska (15)
Nevada (89)
New Hampshire (25)
New Jersey (2744)
New Mexico (13)
New York (2118)
North Carolina (1201)
North Dakota (6)
Northern California (4087)
Ohio (237)
Oklahoma (9)
Oregon (21)
Pennsylvania (1581)
Puerto Rico (21)
Rhode Island (26)
South America (693)
South Carolina (27)
Southern California (3266)
Tennessee (146)
Texas (1239)
United States (29661)
Utah (208)
Vermont (1)
Virginia (293)
Washington D.C. (47)
Washington State (624)
West Virginia (3)
Wisconsin (112)
Wyoming (2)
445,618 Results for "bayer pharmaceuticals corporation ct".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MustGrow Receives First Milestone Payment from Bayer AG
• Bayer AG has paid MustGrow the first development milestone payment. • The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow’s mustard-based biocontrol technologies in Europe, Middle East and Africa.
August 21, 2026
·
6 min read
Press Releases
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
December 2, 2025
·
4 min read
Press Releases
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
June 9, 2026
·
3 min read
Press Releases
U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer
September 9, 2026
·
15 min read
Deals
Bayer ends multi-year M&A drought with up to $2.45B Perfuse buy
For $300 million upfront, Bayer is purchasing Perfuse Therapeutics to advance an eye implant for glaucoma and diabetic retinopathy, marking the company’s first pharma acquisition since 2021.
May 6, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Bayer Completes Acquisition of Perfuse Therapeutics
June 17, 2026
·
3 min read
Press Releases
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
August 30, 2026
·
8 min read
Press Releases
Bayer Advances Combined Seed and Crop Protection Pipeline and Enters Phase of Blockbuster Launches
September 2, 2026
·
10 min read
Press Releases
Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202
September 9, 2026
·
4 min read
Press Releases
BAYER INITIATES PHASE II STUDY OF INVESTIGATIONAL GIRK4 INHIBITOR IN PATIENTS WITH ATRIAL FIBRILLATION
September 9, 2026
·
6 min read
1 of 44,562
Next
